# Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

> **NCT01438177** · PHASE2 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 11 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade
- **DRUG:** Cyclophosphamide
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT01438177
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** PI left institution.
- **Last updated:** 2020-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438177, "Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01438177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*